Feb 14 The U.S. health regulator approved the
first implantable device for treating a rare, genetic, eye
disease that can lead to blindness.
The device, made by Sylmar, California-based Second Sight
Medical Products Inc, includes a small video camera, a
transmitter mounted on a pair of eyeglasses, a video processing
unit and an implanted artificial retina.
The video processing unit transforms images from the video
camera into electronic data that is wirelessly transmitted to
the retina inside the eye.
The eye disease, called retinitis pigmentosa (RP), damages
the light-sensitive cells that line the retina, resulting in the
gradual loss of side vision and night vision, and later of
The device is named Argus II and is intended for use in
adults aged 25 years or older with bare or no light perception
in both eyes, an intact inner layer retina function and a
previous history of the ability to see forms, FDA said.
(Reporting by Esha Dey in Bangalore; Editing by Sreejiraj